solian 100
sanofi-aventis new zealand limited - amisulpride 100mg; ; ; amisulpride 100mg - tablet - 100 mg - active: amisulpride 100mg excipient: hydrated silica lactose monohydrate magnesium stearate methylcellulose potato starch active: amisulpride 100mg excipient: hypromellose lactose monohydrate magnesium stearate microcrystalline cellulose sodium starch glycolate - amisulpride is indicated for the treatment of acute and chronic schizophrenic disorders, in which positive symptoms (such as delusions, hallucinations, thought disorders) and/or negative symptoms (such as blunted affect, emotional and social withdrawal) are prominent, including patients characterised by predominant negative symptoms.
solian 200
sanofi-aventis new zealand limited - amisulpride 200mg; ; ; amisulpride 200mg - tablet - 200 mg - active: amisulpride 200mg excipient: hydrated silica lactose monohydrate magnesium stearate methylcellulose potato starch active: amisulpride 200mg excipient: hypromellose lactose monohydrate magnesium stearate microcrystalline cellulose sodium starch glycolate - amisulpride is indicated for the treatment of acute and chronic schizophrenic disorders, in which positive symptoms (such as delusions, hallucinations, thought disorders) and/or negative symptoms (such as blunted affect, emotional and social withdrawal) are prominent, including patients characterised by predominant negative symptoms.
solian 400
sanofi-aventis new zealand limited - amisulpride 400mg; ; - tablet - 400 mg - active: amisulpride 400mg excipient: hypromellose lactose monohydrate macrogol stearate 2000 magnesium stearate microcrystalline cellulose powdered cellulose sodium starch glycolate titanium dioxide - amisulpride is indicated for the treatment of acute and chronic schizophrenic disorders, in which positive symptoms (such as delusions, hallucinations, thought disorders) and/or negative symptoms (such as blunted affect, emotional and social withdrawal) are prominent, including patients characterised by predominant negative symptoms.
stemetil
sanofi-aventis new zealand limited - prochlorperazine maleate 25mg - suppository - 25 mg - active: prochlorperazine maleate 25mg excipient: suppository base e75 suppository base w35 - prochlorperazine is used for nausea and vomiting from whatever cause. it may also be used for migraine, schizophrenia (particularly in the chronic stage) and acute mania.
stemetil
sanofi-aventis new zealand limited - prochlorperazine maleate 5mg - suppository - 5 mg - active: prochlorperazine maleate 5mg excipient: suppository base e75 suppository base w35
pamid tablets
cts chemical industries ltd, israel - indapamide - tablets - indapamide 2.5 mg - indapamide - indapamide - diuretic for the treatment of hypertension and fluid retention.
ocsaar plus
organon pharma israel ltd., israel - hydrochlorothiazide; losartan potassium - tablets - losartan potassium 50 mg; hydrochlorothiazide 12.50 mg - losartan and diuretics - losartan and diuretics - ocsaar plus is indicated for the treatment of hypertension, for patients in whom combination therapy is appropriate. to reduce the risk of stroke in patients with hyperfension adn left ventricular hypertrophy.
atacand plus
tzamal bio-pharma ltd - candesartan cilexetil; hydrochlorothiazide - tablets - candesartan cilexetil 16 mg; hydrochlorothiazide 12.5 mg - candesartan and diuretics - candesartan and diuretics - essential hypertension, where monotherapy with candesartan cilexetil or hydrochlorothiazide is not sufficient.
atenolol actavis 50 milligram film coated tablet
actavis group ptc ehf - atenolol - film coated tablet - 50 milligram - beta blocking agents, selective
atenolol actavis 25 milligram film coated tablet
actavis group ptc ehf - atenolol - film coated tablet - 25 milligram - beta blocking agents, selective